Skip to main content
logo
Vigonvita Life Sciences Co., Ltd. (HKG:2630)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
86.45
+3.60 (4.35%)
Aug 20, 2026, 4:09 PM HKT

Vigonvita Life Sciences Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Revenue
102.1102.111.83199.65
Revenue Growth
-762.88%-94.07%-
Gross Profit
80.6880.683.49193.64
Operating Income
-334.28-334.28-203.667.25
Net Income
-355.72-355.72-211.412.09
Earnings Per Share
-2.33-2.33-1.450.08
EPS Growth
----

Revenue by Geography
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
People's Republic of China (PRC)
101.94101.9411.79198.98
Uzbekistan
0.160.160.040.67
Total
102.1102.111.83199.65

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Cash & Investments
517.69517.69121.3596.22
Total Debt
646.57646.57427.72321.03
Net Cash (Debt)
-128.88-128.88-306.37-224.81
Net Cash Growth
----
Net Cash Per Share
-0.84-0.84-2.10-1.56

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-96.67-96.67-108.8530.67
Capital Expenditures
-159.97-159.97-77.68-86.72
Free Cash Flow
-256.64-256.64-186.53-56.05
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Gross Margin
79.02%79.02%29.47%96.99%
Operating Margin
-327.41%-327.41%-1721.30%3.63%
Pretax Margin
-349.58%-349.58%-1839.44%3.22%
Profit Margin
-348.42%-348.42%-1786.71%6.05%
FCF Margin
-251.38%-251.38%-1576.46%-28.07%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
PS Ratio
127.53120.74--